Chemical Compound

2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione

CAS Registry Number 121288-39-9
2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione 结构式
Primary record

2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione

库存
9,175 克
纯度
98.4 %
CAS
121288-39-9

化合物标识与属性

CAS
121288-39-9
PubChem CID
135410906
SMILES
C=CCN1C2=C(N=C(NC2=O)N)N(C1=O)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
Canonical SMILES
C=CCn1c(=O)n([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2nc(N)[nH]c(=O)c21

名称与同义词

  • LOXORIBINE
  • Loxoribina
  • 7-allyl-8-oxoguanosine
  • Loxoribinum
  • 121288-39-9
  • (Loxoribine)
  • 7a8oGuo
  • (Loxoribine)"
  • RWJ 21757
  • RWJ-21757
  • 7A8OGua
  • 7-Allyl-7,8-dihydro-8-oxoguanosine
  • Loxoribine [USAN:INN]
  • Loxoribinum [INN-Latin]
  • 9CAS0V66OI
  • Loxoribina [INN-Spanish]
  • Loxoribine < Rec INN
  • UNII-9CAS0V66OI
  • DTXSID3046748
  • AC1L1TTN
  • AC1Q6MTX
  • LOXORIBINE [INN]
  • Loxoribine (USAN/INN)
  • RefChem:924942
  • LOXORIBINE [USAN]
  • D04EIF
  • VDCRFBBZFHHYGT-IOSLPCCCSA-N
  • SCHEMBL61782
  • DTXCID1026748
  • 7-Allyl-78-dihydro-8-oxoguanosine
  • C13H17N5O6
  • CHEMBL292008
  • GTPL5018
  • SCHEMBL16516342
  • 7-Allyl-8-oxo-7,8-dihydroguanosine
  • MFCD00867591
  • GLXC-07304
  • HMS3413D12
  • HMS3677D12
  • 7,8-dihydro-8-oxo-7-allyl-guanosine
  • CID60737
  • ZINC4674533
  • Tox21_112592
  • 7-allyl-7,8-dihydro-8-oxo-guanosine
  • AKOS024284397
  • AKOS040741970
  • C13-H17-N5-O6
  • Tox21_112592_1
  • NA07175
  • Guanosine, 7,8-dihydro-8-oxo-7-(2-propenyl)-
  • NCGC00167840-01
  • NCGC00263547-01
  • 7,8-Dihydro-8-oxo-7-(2-propenyl)guanosine
  • DA-55021
  • SID:53789459
  • ST075699
  • SY347009
  • CID:135410906
  • HY-108472
  • J519.305B
  • 7-Allyl-7,8-dihydro-8-oxoguanosine, 95%
  • CAS-121288-39-9
  • CS-0028896
  • FT-0661508
  • NS00121470
  • 7-(2-Propenyl)-8-oxo-7,8-dihydroguanosine
  • 7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
  • D04787
  • 7-ALLYL-7 8-DIHYDRO-8-OXOGUANOSINE 95
  • 7-Allyl-7,8-dihydro-8-oxoguanosine(Loxoribine)
  • 8-Oxo-7-(prop-2-en-1-yl)-7,8-dihydroguanosine
  • A945142
  • C068562
  • SR-01000883708
  • 7-Allyl-2-amino-9-beta-D-ribofuranosylpurine-6,8(1H,9H)-dione
  • SR-01000883708-1
  • BRD-K00091711-001-01-2
  • BRD-K00091711-001-02-0
  • Q27081526
  • 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-1H-purine-6,8-dione
  • 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-enyl-3H-purine-6,8-dione
  • 2-Azanyl-9-[(2~{r},3~{r},4~{s},5~{r})-5-(Hydroxymethyl)-3,4-Bis(Oxidanyl)oxolan-2-Yl]-7-Prop-2-Enyl-1~{h}-Purine-6,8-Dione
  • AOG
  • 2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione
  • 2-AMINO-9-[(2R,3R,4S,5R)-3,4-DIHYDROXY-5-(HYDROXYMETHYL)OXOLAN-2-YL]-7-(PROP-2-EN-1-YL)-1H-PURINE-6,8-DIONE
  • 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-1H-purine-6,8-dione
  • 2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-(prop-2-en-1-yl)-6,7,8,9-tetrahydro-3H-purine-6,8-dione
  • 7-allyl-2-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-1H-purine-6,8(7H,9H)-dione
  • 7-allyl-2-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purine-6,8-dione
  • 9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-amino-7-prop-2- enyl-1,7-dihydropurine-6,8-dione
  • SDL